trial

Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders

NCTId NCT00914030
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 140 (estimated)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2016-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
140 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2009-06
Primary completion
2016-12
Eligibility
ALL · 7 Years · 55 Years

Interventions & indications

Drugs
Neuropsychological evaluation

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Investigators

1
Anne GIERSCH, MD, PhDPrincipal Investigator

Sites

5 total
Brumath, FranceColmar, FranceLoos, FranceStrasbourg, FranceStrasbourg, France

Facts & assertions

4 sourced
Enrollment
140
Phase
NA
Primary Completion Date
2016-12
Status
UNKNOWN
relationships
The graph out of here
drug
Neuropsychological evaluation
drug
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Schizophrenia
indication
Autism Spectrum Disorder
indication
Schizophrenia
indication
investigator
Anne GIERSCH, MD, PhD
person